Rødland GE, Melhus K, Generalov R, Gilani S, Bertoni F, Dahle J, Syljuåsen RG, Patzke S (2019) The Dual Cell Cycle Kinase Inhibitor JNJ-7706621 Reverses Resistance to CD37-Targeted Radioimmunotherapy in Activated B Cell Like Diffuse Large B Cell Lymphoma Cell Lines Front Oncol, 9, 1301 DOI 10.3389/fonc.2019.01301, PubMed 31850205 Hauge S, Macurek L, Syljuåsen RG (2019) p21 limits S phase DNA damage caused by the Wee1 inhibitor MK1775 Cell Cycle, 18 (8), 834-847 DOI 10.1080/15384101.2019.1593649, PubMed 30943845 Landsverk HB, Sandquist LE, Sridhara SC, Rødland GE, Sabino JC, de Almeida SF, Grallert B, Trinkle-Mulcahy L, Syljuåsen RG (2019) Regulation of ATR activity via the RNA polymerase II associated factors CDC73 and PNUTS-PP1 Nucleic Acids Res, 47 (4), 1797-1813 DOI 10.1093/nar/gky1233, PubMed 30541148 More publications
